Thursday, May 4  | 10:00 am

Longevity Landscape through the Clinical Lens

by Jyothi Devakumar, PhD, Group CSO and Partner at Longevity Tech Fund and Longevity Builders, Palo Alto, CA, USA

Clinicians are always seeking newer and effective ways to help the patients. Emerging science of Longevity offers an opportunity to treat disease even before they develop with novel methods to diagnose, prevent, postpone and even modify the course of disease progression. What stage of clinical development are these new and upcoming therapies in? A peek in to the future of clinical longevity- A decade in the making through the eyes of an investor.

Thursday, May 4  | 10:40 am

Health Longevity Road map in Israel and Sheba Longevity Center

by Tzipi Strauss, Director, Department of Neonatology, Edmond & Lily Safra Children Hospital, Sheba Medical Center, Tel-Hashomer, Israel

Vision and Mission – establishing longevity medicine as a clinical department.

Thursday, May 4  | 11:00 – 11:20 am

One transformative week to live longer, healthier and fuller

by Simone Gibertoni, CEO of Clinique La Praire and Cofounder of Holistic Health by Clinique La Praire (Longevity Supplements), Montreaux, Switzerland

Clinique La Prairie has been pionering longevity since its creation, in 1931. He collaborates with international experts and clinicians in the fields of aging research and biosciences, to continuously bring science-led contribution to its unique approach for Predictive and Precision Medicine. The talk will bring you through a discovery of the clinic advanced concepts and solutions that shape the CLP Longevity Method at the core of each of its renowed health programs. We will cover the assessments and technologies that enable to deliver expert and individualized interventions – the essence of Clinique La Prairie´s Longevity programs.

Friday, May 5  | 14:30 – 14:50 pm

Rejuvenation Biotechnology: Is the finish line in sight?

by Aubrey de Grey, PhD, Co-Founder of Methuselah Foundation, Mountain View, CA, USA

Friday, May 5  | 14:50 – 15:10 pm

The Economic and Societal Landscape of Longevity Science

by Jim Mellon, Chairman of Burnbrae Group, Chairman and Co-Founder of Juvenescence

An examination of how the industry is evolving, its challenges and public perceptions .

Friday, May 5  | 17:00 – 17:20 pm

Opportunities and challenges of longevity bioactives as part of F&B solutions at global scale

by Philipp Gut, M.D. and Head of Data Sciences and Precision Nutrition, Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland

Prevention through nutritional approaches, sometimes referred to as food as medicine, is gaining in importance to address a broad range of non-communicable diseases.  Among such strategies is the use of bioactive molecules from edible sources that can be enriched in supplements, foods, or beverages to complement balanced eating patterns. In this talk, I will summarize opportunities around emerging “longevity bioactives” that target cellular hallmarks of aging to illustrate the potential but also the challenges to use them as part of Food & Beverage (F&B) solutions at a global scale.